.
cambridge's bluebird bio licenses delivery tech to novartis, gsk.
18 hours ago.
meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world..
.
.
.: "fremanezumab for the preventive treatment of chronic migraine."